Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bordetella bronchiseptica is a small, Gram-negative, aerobic, motile, rod-shaped bacterium commonly found in the respiratory tract of animals, especially dogs and cats, where it causes highly contagious respiratory disease (kennel cough in dogs, bordetellosis in cats); it can persist in the environment for extended periods and rarely causes infections in humans, primarily infecting the immunocompromised. Its pathogenicity is due to a suite of virulence factors (adhesins such as filamentous hemagglutinin, fimbriae, pertactin; toxins like dermonecrotic toxin; flagella), and its expression of virulence genes is tightly regulated by the BvgAS two-component regulatory system
Inhibition of bacterial cell wall synthesis (by certain β-lactams), inhibition of protein synthesis (by tetracyclines and aminoglycosides), lytic activity (by bacteriophages)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella bronchiseptica.